uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted July 03, 2018

Seller of Chinese "Cancer" Supplements Warned

On June 26, 2018, the FDA issued a warning letter to the American Chinese Medicine Association (ACMA), following a a review of the company's website, which found statements made about its products, including ACMA Brain Tumor Treatment, ACMA Breast Cancer Treatment, ACMA Colon Cancer Treatment, ACMA Multiple Myeloma Treatment, and ACMA Lyme Disease Treatment to be drug claims.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at